Pfizer

Understanding mRNA Vaccines

Scientists at Pfizer are breaking barriers with mRNA technology, one of the approaches used to develop COVID-19 vaccines.

Researcher Profile: Dr. Yasmeen Agosti

At Pfizer, Yasmeen works to develop maternal vaccines that have the potential to help prevent diseases from affecting at-risk infants.

Researcher Profile: Dr. Marie-Claire Peakman

Dr. Marie-Claire Peakman always knew she wanted to make a difference in the world.

Researcher Profile: Dr. Leonardo Salese, MD

Why innovation is vital: My battle with C. difficile

Simon Jenkins, who suffered from C. diff, shares his story and hope for future treatments.

Researcher Profile: Michael Pride

To demonstrate the incredible work pursued by America's biopharmaceutical researchers, we're sharing the story of Dr. Michael Pride, a Pfizer scientist who is working on preventative vaccines for the bacterium Clostridium difficile (C. difficile).

I Just Want to Show Other Patients that Anything is Possible

Today is World Duchenne Awareness Day, which aims to raise awareness for people living with Duchenne muscular dystrophy (DMD).

Researcher Profile: Jane Owens

Dr. Owens is a senior director who manages rare muscle disease research projects in Pfizer's Rare Disease Research Unit.

Vaccines: Cutting Health Care Costs While Saving Countless Lives

In the United States, 16 diseases are now preventable as a result of childhood vaccines, resulting in an estimated $1.4 trillion in societal costs saved.

Researcher Profile: Ted Johnson

Ted Johnson has spent his career working to find better and more innovative treatments for cancer.

Lung Cancer Gets Personal

Lung cancer counts for 25% of all cancer deaths in the U.S. That's why every day, researchers search relentlessly to unearth more innovative breakthroughs. Thanks to their dedication, there are now 240 immuno-oncology treatments in development to give hope and a future for patients with cancer.

Researcher Profile: Kelly Knee

As a principal scientist working on sickle cell disease in the Rare Disease Research Unit (RDRU) at Pfizer, Kelly Knee is a jack of all trades.

Recognizing Diversity in Clinical Trials

Every time you take a medicine – even if it's just for a headache – you are benefitting from the results of a clinical trial.

Battling Cancer Together

At age 24, medical student Matt Hiznay was diagnosed with stage IV lung cancer.

Building "Smart Bombs" to Attack Cancer

Biopharmaceutical researchers are investigating a new type of therapy that has the potential to attack cancer cells while leaving healthier cells unharmed.